Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02079584 · ClinicalTrials.gov registry record
Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific Anticoagulant
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 83
- Enrollment target
NCT02079584: Completed study, sponsored by Indiana University.
NCT02079584 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 83 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02079584 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 83 participants
- Enrollment target
Study Summary
The objectives of this registry are to measure the outcomes, cost, adherence pattern and experience of patients treated as outpatients with rivaroxaban after being diagnosed with blood clots in the emergency department. The investigators hypothesize that patients will have a relatively low rate of adverse events and higher adherence than has been reported historically for warfarin treatment. Patients will be scheduled for follow up care with one of Dr. Kline's Outpatient Thrombosis clinics at Methodist Hospital, Eskenazi Health Services and the Baylor University Medical Center (Dallas, TX) after diagnosis and treatment of pulmonary embolism (PE) or deep vein thrombosis (DVT).
Primary Outcome
The primary outcome is clot recurrence, with the rivaroxaban cohort expected to be equivalent or improved with warfarin.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2013-03 |
| Est. Completion | 2014-08-14 |
What the finished NCT02079584 record still lists
NCT02079584 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 83 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02079584 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02079584 about?
NCT02079584 is a clinical study titled "Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific Anticoagulant". The objectives of this registry are to measure the outcomes, cost, adherence pattern and experience of patients treated as outpatients with rivaroxaban after being diagnosed with blood clots in the emergency department. The investigators hypothesize that patients will have a relatively low rate of a...
What is the current status of trial NCT02079584?
This trial is currently completed. The enrollment target is 83 participants. The study started on 2013-03. Estimated completion is 2014-08-14.
Who is sponsoring clinical trial NCT02079584?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia